Environmental justice and primary prevention of cancer: The odyssey and legacy of Lorenzo tomatis

New Solutions

Volumn 22, Issue 1, 2012, Pages 7-17

  Huff, James ^a   Melnick, Ronald ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cancer bioassay; Chemical carcinogens; Environmental carcinogens; IARC monographs; Lorenzo Tomatis; Primary prevention; Social justice

Indexed keywords

ARTICLE; ENVIRONMENT; HISTORY; HUMAN; MALE; NEOPLASM; OCCUPATIONAL EXPOSURE; PRIMARY PREVENTION; SOCIAL JUSTICE;

ENVIRONMENT; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MALE; NEOPLASMS; OCCUPATIONAL EXPOSURE; PRIMARY PREVENTION; SOCIAL JUSTICE;

EID: 84864039430     PISSN: 10482911     EISSN: 15413772     Source Type: Journal    
DOI: 10.2190/NS.22.1.b     Document Type: Article

References (87)

1. P. Landrigan, “Doctor Lorenzo Tomatis (1929-2007),” European Journal of Oncology 12(4) (2007): 283.
2. J. Huff and R. Melnick, “Lorenzo Tomatis 1929–2007. In Memoriam,” Environmental Health Perspectives 116(1) (2008): A16-7, http://dx.doi.org/10.1289/ehp.116-a16.
3. B. Terracini, “Lorenzo Tomatis and Environmental Cancer Risk,” Annali dell’Istituto Superiore di Sanità 44(1) (2008): 5-7.
4. B. Terracini, “In Memoriam Lorenzo Tomatis,” International Journal of Occupational and Environmental Health 14(2) (2008): 83-5.
5. R. Montesano, “An Appreciation of Lorenzo Tomatis by a Friend and Colleague,” Carcinogenesis 29(5) (2008): 889, http://dx.doi.org/10.1093/carcin/bgm273.
6. G. A. Zapponi, I. Marcello, and A. Carere, “Prevention, Ethics and Science: Lessons from Lorenzo Tomatis,” Annali dell’Istituto superiore di sanità 44(1) (2008): 8-12.
7. J. Huff, “Lorenzo Tomatis, 3 January 1929–21 September 2007,” European Journal of Oncology 14(3) (2009): 125-32.
8. P. Vineis and R. Saracci R., eds., “Proceedings of the First Lorenzo Tomatis Conference on Environment and Cancer” [Turin, Italy 4-5 June 2009], Environmental Health 10 Suppl 1 (2011), http://www.ehjournal.net/supplements/10/S1.
9. R. L. Melnick and J. Huff, “Lorenzo Tomatis and Primary Prevention of Environmental Cancer,” Environironmental Health 10 (Suppl 1) (2011): S14, http://dx.doi.org/10.1186/1476-069X-10-S1-S14.
10. R. Saracci and P. Vineis, “Environment and Cancer: the Legacy of Lorenzo Tomatis,” Environironmental Health 10 (Suppl 1) (2011): S1, http://www.ehjournal.net/content/10/S1/S1.
11. L. Tomatis, “The Predictive Value of Rodent Carcinogenicity Tests in the Evaluation of Human Risks,” Annual Reviews of Pharmacology and Toxicology 19 (1979): 511-30, http://dx.doi.org/10.1146/annurev.pa.19.040179.002455.
12. L. Tomatis, “How Much of the Human Disease Burden is Attributable to Environmental Chemicals?” Toxicology Letters 77(1-3) (1995): 1-8, http://dx.doi.org/10.1016/0378-4274(95)03264-9.
13. L. Tomatis et al., “Avoided and Avoidable Risks of Cancer,” Carcinogenesis 18(1) (1997): 97-105, http://dx.doi.org/10.1093/carcin/18.1.97.
14. L. Tomatis et al., “Alleged Misconceptions Distort Perceptions of Environmental Cancer Risks,” The FASEB Journal 15(1) (2001): 195-203, http://dx.doi.org/10.1096/fj.99-1056com.
15. L. Tomatis and J. Huff, “Evolution of Cancer Etiology and Primary Prevention,” Environmental Health Perspectives 109(10) (2001): A458-60, http://dx.doi.org/10.1289/ehp.109-a458.
16. L. Tomatis and J. Huff, “Evolution of Research on Cancer Etiology,” in The Molecular Basis of Human Cancer: Genomic Instability and Molecular Mutation in Neoplastic Transformation, eds. W. B. Coleman and G. J. Tsongalis (Totowa, NJ: Humana Press Inc., 2002), 189-201.
17. L. Tomatis, “Contribution of Experimental Cancerogenesis to the Primary Prevention of Human Tumors,” La Medicina del Lavoro 73(5) (1982): 471-81. [in Italian]
18. L. Tomatis, “Exposures Associated with Cancer in Humans,” Journal of Cancer Research and Clinical Oncology 108(1) (1984): 6-10, http://dx.doi.org/10.1007/BF00390967.
19. L. Tomatis, “The Contribution of Epidemiological and Experimental Data to the Control of Environmental Carcinogens,” Cancer Letters 26(1) (1985): 5-16, http://dx.doi.org/10.1016/0304-3835(85)90167-3.
20. L. Tomatis, “The Contribution of the IARC Monographs Program to the Identification of Cancer Risk Factors,” Annals of the New York Academy of Sciences 534 (1988): 31-8, http://dx.doi.org/10.1111/j.1749-6632.1988.tb30086.x.
21. L. Tomatis, “Environmental Cancer Risk Factors. A Review,” Acta Oncologica 27(5) (1988): 465-72, http://dx.doi.org/10.3109/02841868809093572.
22. L. Tomatis et al., “Human Carcinogens So Far Identified,” Japanese Journal of Cancer Research: Gann 80(9) (1989): 795-807, http://dx.doi.org/10.1111/j.1349-7006.1989.tb01717.x.
23. L. Tomatis (ed.), “Cancer: Causes, Occurrence and Control,” IARC Scientific Publication No. 100 (1990): 1-368.
24. L. Tomatis and J. Huff, “Evidence of Carcinogenicity of DDT in Nonhuman Primates,” Journal of Cancer Research and Clinical Oncology 126(4) (2000): 246, http://dx.doi.org/10.1007/s004320050040.
25. L. Tomatis, “The Identification of Human Carcinogens and Primary Prevention of Cancer,” Mutation Research 462(2-3) (2000): 407-21, http://dx.doi.org/10.1016/S1383-5742(00)00029-6.
26. J. Huff and L. Tomatis, “Long-Term Toxicity and Carcinogenicity Study of Cyclamate in Nonhuman Primates (Takayama et al., Toxicological Sciences 53, 33-39),” Toxicological Sciences 57(1) (2000): 186.
27. J. K. Haseman et al., “Carcinogenesis Bioassays: Study Duration and Biological Relevance,” Food and Chemical Toxicology 39(7) (2001): 739-44.
28. V. Gennaro and L. Tomatis, “Business Bias: How Epidemiologic Studies May Underestimate or Fail to Detect Increased Risks of Cancer and Other Diseases,” International Journal of Occupational and Environmental Health 11(4) (2005): 356-9.
29. L. Tomatis, “Identification of Carcinogenic Agents and Primary Prevention of Cancer,” Annals of the New York Academy of Sciences 1076 (2006): 1-14, http://dx.doi.org/10.1196/annals.1371.039. [Tomatis received the Ramazzini Award in 2005; this was his Ramazzini Acceptance Lecture]
30. L. Tomatis, “An Efficient Primary Prevention of Cancer Requires an Integrated Approach: Mühlbock Memorial Lecture,” European Journal of Cancer & Clinical Oncology 23(11) (1987): 1571-5, http://dx.doi.org/10.1016/0277-5379(87)90432-9.
31. L. Tomatis, “Toward the Development of an Equitable Cancer Prevention,” Cancer Letters 15; 83(1-2) (1994): 139-42.
32. L. Tomatis, “Limitations and Inconsistencies in the Approaches to Cancer Prevention,” Teratogenesis, Carcinogenesis, and Mutagenesis 15(6) (1995-1996): 277-82, http://dx.doi.org/10.1002/(SICI)1520-6866(1996)15:6<277::AID-TCM4>3.3.CO:2-W.
33. L. Tomatis, “What Priorities in Prevention?,” La Medicina del Lavoro 89(2) (1998): 96-7. [in Italian]
34. L. Tomatis, “Etiology and Primary Prevention of Cancer,” Advances in Clinical Pathology 2(3) (1998): 193-195.
35. L. Tomatis, “Etiologic Evidence and Primary Prevention of Cancer,” Drug Metabolism Reviews 32(2) (2000): 129-37, http://dx.doi.org/10.1081/DMR-100100566.
36. L. Tomatis, “Prevention Between Precaution and Responsibility,” Epidemiologia e Prevenzione 25(4) (2001): 149-51. [in Italian]
37. J. Huff et al., “Primary Prevention of Cancer,” The Scientist 16(18) (2002): 10-11.
38. L. Tomatis, “Primary Prevention Protects Public Health,” Annals of the New York Academy of Sciences 982 (2002): 190-7, http://dx.doi.org/10.1111/j.1749-6632.2002.tb04933.x.
39. L. Tomatis, “Primary Prevention of Cancer in Relation to Science, Sociocultural Trends and Economic Pressures,” Scandinavian Journal of Work, Environment & Health 31(3) (2005): 227-32.
40. L. Tomatis, “How Primary Prevention Should Change,” Epidemiologia e Prevenzione 29(5-6 Suppl.) (2005): 8-12. [in Italian]
41. L. Tomatis, “Role of Experimental and Epidemiological Evidence of Carcinogenicity in the Primary Prevention of Cancer,” Annali dell‘Istituto Superiore di Sanità 42(2) (2006): 113-7.
42. L. Tomatis, “Poverty and Cancer,” Cancer Epidemiology, Biomarkers & Prevention 1(3) (1992): 167-75.
43. L. Tomatis, “Age and Poverty as Risk Factors,” Environmental Health Perspectives 102(8) (1994): 620, http://dx.doi.org/10.1289/ehp.94102620.
44. L. Tomatis, “Can Social Injustice be Compensated Adequately?”. Epidemiologia e Prevenzione 18(60) (1994): 135-40. [English, Italian]
45. L. Tomatis, “Socioeconomic Factors and Human Cancer,” International Journal of Cancer 62(2) (1995): 121-5, http://dx.doi.org/10.1002/ijc.2910620202.
46. L. Tomatis, “Ethical Aspects of Prevention,” Scandinavian Journal of Work, Environment & Health 21(4) (1995): 245-51.
47. L. Tomatis, “Poverty and Cancer,” IARC Scientific Publication 138 (1997): 25-39.
48. L. Tomatis, “Inequalities in Cancer Risks,” Seminars in Oncology 28(2) (2001): 207-9, http://dx.doi.org/10.1053/sonc.2001.21968.
49. L. Tomatis, “The IARC Program on the Evaluation of the Carcinogenic Risk of Chemicals to Man,” Annals of the New York Academy of Sciences 271 (1976): 396-409, http://dx.doi.org/10.1111/j.1749-6632.1976.tb23139.x.
50. L. Tomatis et al., “Evaluation of the Carcinogenicity of Chemicals: A Review of the Monograph Program of the International Agency for Research on Cancer (1971 to 1977),” Cancer Research 38(4) (1978): 877-85.
51. J. Huff et al., “Evaluation of Chemical Carcinogenesis Data: The International Agency for Research on Cancer,” Forum for the Advancement of Toxicology News 11(4) (1978): 1-2.
52. L. Tomatis et al., “International Agency for Research on Cancer Monograph Programme: The First Seven Years” (“Programme de Monographies du Centre International de Recherche sur le Cancer: Les Sept Premieres Annees”), International Register of Potentially Toxic Chemicals (United Nations) Bulletin 1(2) (1978): 3-4.
53. R. Althouse et al., “Chemicals and Industrial Processes Associated with Cancer in Humans, IARC Monographs, Volumes 1 to 20,” IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Supplement 1 (1979): 1-71.
54. J. Huff et al., International Agency for Research on Cancer, Survey of Chemicals Being Tested for Carcinogenicity, International Register of Potentially Toxic Chemicals (United Nations) Bulletin 2(1) (1979): 5.
55. R. Althouse et al., “An Evaluation of Chemicals and Industrial Processes Associated with Cancer in Humans Based on Human and Animal Data: IARC Monographs Volumes 1 to 20,” Cancer Research 40(1) (1980): 1-12.
56. H. Bartsch and L. Tomatis, “Comparison between Carcinogenicity and Mutagenicity Based on Chemicals Evaluated in the IARC Monographs,” Environmental Health Perspectives 47 (1983): 305-17, http://dx.doi.org/10.2307/3429518.
57. L. Tomatis, “Relation between Mutagenesis, Carcinogenesis and Teratogenesis—Experience from the IARC Monographs Programme,” Progress in Clinical and Biological Research 209B (1986): 3-12.
58. L. Simonato and L. Tomatis, “The International Agency for Research on Cancer Experience in the Evaluation of the Carcinogenic Risk to Humans,” La Medicina del Lavoro 77(4) (1986): 323-9.
59. H. Vainio et al., “The IARC Classification System for Carcinogens,” American Journal of Industrial Medicine 20(6) (1991): 819-22, http://dx.doi.org/10.1002/ajim.4700200618.
60. L. Tomatis, “Cell Proliferation and Carcinogenesis: A Brief History and Current View Based on an IARC Workshop Report,” Environmental Health Perspectives 101 Suppl 5 (1993): 149-51, http://dx.doi.org/10.2307/3431859.
61. L. Tomatis, “The IARC Monographs Program: Changing Attitudes towards Public Health,” International Journal of Occupational and Environmental Health 8(2) (2002): 144-52.
62. J. Huff, “IARC Monographs, Industry Influence, and Upgrading, Downgrading, and Under-Grading Chemicals: A Personal Point of View,” International Journal of Occupational and Environmental Health 8(3) (2002): 249-70.
63. L. Tomatis, “A Brief History of the International Agency for Research on Cancer (IARC),” Voprosy Onkologii 51(4) (2005): 401-6. [in Russian]
64. IARC, Some Inorganic Substances, Chlorinated Hydrocarbons, Aromatic Amines, N-Nitroso Compounds, and Natural Products, IARC Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Humans 1 (1972): 1-184.
65. IARC, Hepatitis Viruses, IARC Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Humans 59 (1994): 1-255.
66. IARC, Some Fumigants, the Herbicides 2,4-D and 2,4,5-T, Chlorinated Dibenzodioxins and Miscellaneous Industrial Chemicals, IARC Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Humans 15 (1997): 1-354.
67. IARC, Some Non-Nutritive Sweetening Agents, IARC Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Humans 22 (1980): 1-208.
68. J. Huff, “Primary Prevention of Cancer,” Science 332(6032) (2011): 916-7, http://dx.doi.org/10.1126/science.332.6032.916-b.
69. IARC, “Agents Classified by the IARC Monographs, Volumes 1-100,” http://monographs.iarc.fr/ENG/Classification/index.php (accessed January 2012).
70. NTP, “12th Report on Carcinogens (RoC),” http://ntp.niehs.nih.gov/go/roc12 (accessed January 2012).
71. CalEPA, “Chemicals Known to the State to Cause Cancer or Reproductive Toxicity,” 2011, http://www.oehha.ca.gov/prop65/prop65_listfiles/P65List031811links.pdf (accessed January 2012).
72. M. Soffritti et al., “Ramazzini Foundation Cancer Program: History and Major Projects, Life-Span Carcinogenicity Bioassay Design, Chemicals Studied, and Results,” Annals of the New York Academy of Sciences 982 (2002): 26-45, http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.2002.tb04923.x/pdf.
73. L. Tomatis, “Prenatal Exposure to Chemical Carcinogens and its Effect on Subsequent Generations,” National Cancer Institute Monograph 51 (1979): 159-84.
74. L. Tomatis et al., “Increased Cancer Incidence in the Progeny of Male Rats Exposed to Ethylnitrosourea before Mating,” International Journal of Cancer 28(4) (1981): 475-8, http://dx.doi.org/10.1002/ijc.2910280413.
75. L. Tomatis, “Prenatal Carcinogenesis,” IARC Scientific Publication No. 92 (1988): 121-32.
76. L. Tomatis, “Overview of Perinatal and Multigeneration Carcinogenesis,” IARC Scientific Publication No. 96 (1989): 1-15.
77. V. S. Turusov et al., “Occurrence of Tumours in the Descendants of CBA Male Mice Prenatally Treated with Diethylstilbestrol,” International Journal of Cancer 50(1) (1992): 131-5, http://dx.doi.org/10.1002/ijc.2910500126.
78. A. Loktionov et al., “Transplacental and Transgeneration Carcinogenic Effect of 7,12-dimethylbenz(a)anthracene: Relationship with ras Oncogene Activation,” Carcinogenesis 13(1) (1992): 19-24, http://dx.doi.org/10.1093/carcin/13.1.19.
79. M. Marselos and L. Tomatis, “Diethylstilboestrol: II, Pharmacology, Toxicology and Carcinogenicity in Experimental Animals,” European Journal of Cancer 29A(1) (1992): 149-55, http://dx.doi.org/10.1016/0959-8049(93)90597-9.
80. H. Yamasaki, A. Loktionov, and L. Tomatis, “Perinatal and Multigenerational Effect of Carcinogens: Possible Contribution to Determination of Cancer Susceptibility,” Environmental Health Perspectives 98 (1992): 39-43, http://dx.doi.org/10.2307/3431245.
81. U. Mohr et al., “Increased Risk of Cancer in the Descendants of Syrian Hamsters Exposed Prenatally to Diethylnitrosamine (DEN),” International Journal of Cancer 63(1) (1995): 86-91, http://dx.doi.org/10.1002/ijc.2910630116.
82. V. S. Turusov and L. Tomatis, “Transplacental and Transgenerational Carcinogenesis,” Arkhiv patologii 59(5) (1997): 7-12. [in Russian]
83. L. Tomatis and C. M. Goodall, “The Occurrence of Tumours in F1, F2, and F3 Descendants of Pregnant Mice Injected with 7,12-dimethylbenz(a)anthracene,” International Journal of Cancer 4(2) (1969): 219-25, http://dx.doi.org/10.1002/ijc.2910040212.
84. L. Tomatis, J. Hilfrich, and V. Turusov, “The Occurrence of Tumours in F1, F2 and F3 Descendants of bd Rats Exposed to N-nitrosomethylurea during Pregnancy,” International Journal of Cancer 15(3) (1975): 385-90, http://dx.doi.org/10.1002/ijc.2910150304.
85. L. Tomatis, V. Ponomarkov, and V. Turusov, “Effects of Ethylnitrosourea Administration during Pregnancy on Three Subsequent Generations of BDVI Rats,” International Journal of Cancer 19(2) (1997): 240-8, http://dx.doi.org/10.1002/ijc.2910190214.
86. L. Tomatis, S. Narod, and H. Yamasaki, “Transgeneration Transmission of Carcinogenic Risk,” Carcinogenesis 13(2) (1992): 145-51, http://dx.doi.org/10.1093/carcin/13.2.145.
87. L. Tomatis, “Transgeneration Carcinogenesis: A Review of the Experimental and Epidemiological Evidence,” Japanese Journal of Cancer Research: Gann 85(5) (1994): 443-54, http://dx.doi.org/10.1111/j.1349-7006.1994.tb02378.x.